九典制药(300705) - 九典制药投资者关系管理信息

Group 1: Sales Performance - The sales ratio of Loxoprofen Sodium Gel Patch in hospitals was 94.16% in 2023, while the sales ratio outside hospitals was 5.84%. In Q1 2024, the hospital sales ratio was 82.34%, and the outside sales ratio was 17.66% [2] Group 2: Product Pricing - The price of Ketoprofen Gel Patch is 8.68 CNY/patch, while the winning bid prices for Loxoprofen Sodium Gel Patch in various regions are 18.19 CNY/patch in Guangdong and 17.37 CNY/patch in Zhejiang and Yunnan. The price of Flurbiprofen Gel Patch is around 9.24 CNY/patch [3] Group 3: Product Development and Market Positioning - The company is progressing smoothly with the development of Ketoprofen Gel Patch and has plans for future products including Lidocaine Gel Patch and others that have completed production applications [3] - The marketing channels for Loxoprofen Sodium Gel Patch and Ketoprofen Gel Patch are similar, but their sales models and price ranges differ significantly [3] Group 4: Sales Expense Management - The sales expense ratio is expected to decrease due to the implementation of national and provincial centralized procurement, as well as the transition to a semi-self-operated model and increased promotion in the OTC market [3] Group 5: M&A Plans - The company is considering external mergers and acquisitions and is currently looking for targets that align with its development strategy [4]